According to the company, the new, 225,000-square-foot expansion is a "crucial component" of a more than $12 billion infusion ...

New facility will manufacture HPV vaccines Gardasil and Gardasil 9. Merck plans to invest $8 billion more in U.S. by 2028. A ...

Merck says the expansion in Durham is part of more than $12 billion the company has invested in U.S. manufacturing and ...

At its sprawling complex in Durham, N.C., Merck has opened a new $1 billion, 225,000-square-foot manufacturing plant slated ...

Serum Institute of India is the largest manufacturer of BCG vaccines in the world, while Merck & Co., based in New Jersey, currently is the only manufacturer of BCG (TICE® BCG) in the U.S ...

ImmunityBio, Inc. , a leading immunotherapy company, today announced U.S. Urology Partners, one of the nation's largest independent providers of urology and related specialty services, is one of the ...

Introduction Vaccines are biological preparations that stimulate the immune system to develop protection against specific infectious diseases.

Anktiva becomes another option for BCG-unresponsive BMIBC patients alongside MSD/Merck & Co’s PD-1 inhibitor Keytruda (pembrolizumab) – approved by the FDA in 2020 – and Ferring Pharma’s ...